How tough is brittle bone? Investigating osteogenesis imperfecta in mouse bone

Journal of Bone and Mineral Research

Volumn 29, Issue 6, 2014, Pages 1392-1401

  Carriero, Alessandra ^a,b,c   Zimmermann, Elizabeth A ^b,c   Paluszny, Adriana ^a   Tang, Simon Y ^d   Bale, Hrishikesh ^b,c   Busse, Bjorn ^b,c   Alliston, Tamara ^d   Kazakia, Galateia ^d   Ritchie, Robert O ^b,c   Shefelbine, Sandra J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c Lawrence Berkeley National Laboratory   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BONE FRACTURE; BRITTLE BONE; CRACK GROWTH; CRACK INITIATION; FRACTURE MECHANICS; MOUSE BONE

Indexed keywords

COLLAGEN; ADVANCED GLYCATION END PRODUCT; FIBRILLAR COLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE FRAGILITY; BONE GROWTH; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; INFRARED SPECTROSCOPY; MALE; MOUSE; NONHUMAN; OSTEOGENESIS IMPERFECTA; PLASTICITY; SCANNING ELECTRON MICROSCOPY; TISSUE LEVEL; WIDE ANGLE X RAY SCATTERING; X RAY ANALYSIS; X RAY CRYSTALLOGRAPHY; ANIMAL; BIOMECHANICS; BONE; C57BL MOUSE; COMPUTER SIMULATION; FRACTURE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SMALL ANGLE SCATTERING; ULTRASTRUCTURE; X RAY DIFFRACTION;

ANIMALS; BIOMECHANICAL PHENOMENA; BONE AND BONES; BONE DENSITY; COMPUTER SIMULATION; FIBRILLAR COLLAGENS; FRACTURES, BONE; GLYCOSYLATION END PRODUCTS, ADVANCED; MICE; MICE, INBRED C57BL; OSTEOGENESIS IMPERFECTA; SCATTERING, SMALL ANGLE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TOMOGRAPHY, X-RAY COMPUTED; X-RAY DIFFRACTION;

EID: 84900010719     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2172     Document Type: Article

References (63)

1. Forlino A, Cabral WA, Barnes AM, Marini JC., New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol. 2011; 7: 540-57.
2. Cole WG., The Nicholas Andry Award-1996. The molecular pathology of osteogenesis imperfecta. Clin Orthop Relat Res. 1997; 343: 235-48.
3. Cole WG., Advances in osteogenesis imperfecta. Clin Orthop Relat Res. 2002; 401: 6-16.
4. Rauch F, Glorieux FH., Osteogenesis imperfecta. Lancet. 2004; 363 (9418): 1377-85.
5. Rauch F, Travers R, Parfitt AM, Glorieux FH., Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone. 2000; 26 (6): 581-9.
6. Traub W, Arad T, Vetter U, Weiner S., Ultrastructural studies of bones from patients with osteogenesis imperfecta. Matrix Biol. 1994; 14: 337-45.
7. Alman B, Frasca P., Fracture failure mechanisms in patients with osteogenesis imperfecta. J Orthop Res. 1987; 5 (1): 139-43.
8. Jameson J, Albert C, Busse B, Smith P, Harris G., 3D micron-scale imaging of the cortical bone canal network in human osteogenesis imperfecta (OI). Proc SPIE 8672, Medical Imaging 2013: Biomedical Applications in Molecular, Structural, and Functional Imaging. 2013 Mar 29.
9. Fratzl P, Paris O, Klaushofer K, Landis WJ., Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering. J Clin Invest. 1996; 97: 396-402.
10. Chipman SD, Sweet HO, McBride DJ Jr, et al. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci USA. 1993; 90 (5): 1701-5.
11. Grabner B, Landis WJ, Roschger P, et al. Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim). Bone. 2001; 29 (5): 453-7.
12. Kalajzic I, Terzic J, Rumboldt Z, et al. Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse. Endocrinology. 2002; 143 (5): 1594-601.
13. McBride DJ Jr, Shapiro JR, Dunn MG., Bone geometry and strength measurements in aging mice with the oim mutation. Calcif Tissue Int. 1998; 62 (2): 172-6.
14. Miller E, Delos D, Baldini T, Wright TM, Pleshko Camacho N., Abnormal mineral-matrix interactions are a significant contributor to fragility in oim/oim bone. Calcif Tissue Int. 2007; 81: 206-14.
15. Phillips CL, Bradley DA, Schlotzhauer CL, et al. Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density. Bone. 2000; 27 (2): 219-26.
16. Saban J, Zussman MA, Havey R, Patwardhan AG, Schneider GB, King D., Heterozygous oim mice exhibit a mild form of osteogenesis imperfecta. Bone. 1996; 19 (6): 575-9.
17. Sims TJ, Miles CA, Bailey AJ, Camacho NP., Properties of collagen in OIM mouse tissues. Connect Tissue Res. 2003; 44: 202-5.
18. Vanleene M, Shefelbine SJ., Therapeutic impact of low amplitude high frequency whole body vibrations on the osteogenesis imperfecta mouse bone. Bone. 2013; 53: 507-14.
19. Guillot PV, Abass O, Bassett JH, et al. Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood. 2008; 111: 1717-25.
20. Vanleene M, Saldanha Z, Cloyd KL, et al. Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties. Blood. 2011; 117 (3): 1053-60.
21. Rao SH, Evans KD, Oberbauer AM, Martin RB., Bisphosphonate treatment in the oim mouse model alters bone modeling during growth. J Biomech. 2008; 41 (16): 3371-6.
22. Bargman R, Huang A, Boskey AL, Raggio C, Pleshko N., RANKL inhibition improves bone properties in a mouse model of osteogenesis imperfecta. Connect Tissue Res. 2010; 51 (2): 123-31.
23. Nicholls AC, Osse G, Schloon HG, et al. The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta. J Med Genet. 1984; 21 (4): 257-62.
24. Carriero A, Doube M, Levchuck A, Schneider P, Muller R, Shefelbine SJ., Cortical tissue porosity of brittle osteogenesis imperfecta bone. Presented at: 57th Annual Meeting of the Orthopaedic Research Society; January 13-16, 2011; Long Beach, CA.
25. Vanleene M, Porter A, Guillot PV, Boyde A, Oyen M, Shefelbine S., Ultra-structural defects cause low bone matrix stiffness despite high mineralization in osteogenesis imperfecta mice. Bone. 2012; 50: 1317-23.
26. Camacho NP, Hou L, Toledano TR, et al. The material basis for reduced mechanical properties in oim mice bones. J Bone Miner Res. 1999; 14: 264-72.
27. ASTM-E1820-09. Standard test method for measurement of fracture toughness. Annual book of Americal Society for Testing and Material Standards. West Conshohocken, PA: ASTM International; 2006.
28. ASTM-D790-10. Standard test method for flexural properties of reinforced plastics and electrical insulation materials. Annual book of Americal Society for Testing and Material Standards. West Conshohocken, PA: ASTM International; 2010.
29. Ritchie RO, Koester KJ, Ionova S, Yao W, Lane NE, Ager JW 3rd., Measurement of the toughness of bone: a tutorial with special reference to small animal studies. Bone. 2008; 43: 798-812.
30. Schneider CA, Rasband WS, Eliceiri KW., NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012; 9 (7): 671-5.
31. Paluszny A, Zimmerman RW., Numerical simulation of multiple 3D fracture propagation using arbitrary meshes. Comput Methods Appl Mech Eng. 2011; 200: 953-66.
32. Taylor D, Prendergast PJ., A model for fatigue crack propagation and remodelling in compact bone. Proc Inst Mech Eng H. 1997; 211 (5): 369-75.
33. Taylor D, Lee TC., Microdamage and mechanical behaviour: predicting failure and remodelling in compact bone. J Anat. 2003; 203 (2): 203-11.
34. Taylor D, Tilmans A., Stress intensity variations in bone microcracks during the repair process. J Theor Biol. 2004; 229: 169-77.
35. Wright TM, Hayes WC., The fracture mechanics of fatigue crack propagation in compact bone. J Biomed Mater Res. 1976; 10: 637-48.
36. Barth HD, Launey ME, MacDowell AA, Ager JW, Ritchie RO., On the effect of X-ray irradiation on the deformation and fracture behavior of human cortical bone. Bone. 2010; 46: 1475-85.
37. Gupta HS, Seto J, Wagermaier W, Zaslansky P, Boesecke P, Fratzl P., Cooperative deformation of mineral and collagen in bone at the nanoscale. Proc Natl Acad Sci USA. 2006; 103: 17741-6.
38. Sell DR, Monnier VM., Isolation, purification and partial characterization of novel fluorophores from aging human insoluble collagen-rich tissue. Connect Tissue Res. 1989; 19 (1): 77-92.
39. Woessner JF Jr., The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys. 1961; 93: 440-7.
40. Saito M, Marumo K., Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int. 2010; 21: 195-214.
41. Miles CA, Sims TJ, Camacho NP, Bailey AJ., The role of the alpha2 chain in the stabilization of the collagen type I heterotrimer: a study of the type I homotrimer in oim mouse tissues. J Mol Biol. 2002; 321: 797-805.
42. Bell KL, Loveridge N, Power J, Garrahan N, Meggitt BF, Reeve J., Regional differences in cortical porosity in the fractured femoral neck. Bone. 1999; 24 (1): 57-64.
43. Yeni YN, Brown CU, Wang Z, Norman TL., The influence of bone morphology on fracture toughness of the human femur and tibia. Bone. 1997; 21 (5): 453-9.
44. Launey ME, Buehler MJ, Ritchie RO., On the mechanistic origins of toughness in bone. Ann Rev Mater Res. 2010; 40: 25-53.
45. Koester KJ, Ager JW, Ritchie RO., The true toughness of human cortical bone measured with realistically short cracks. Nat Mater. 2008; 7: 672-7.
46. Zimmermann EA, Schaible E, Bale H, et al. Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales. Proc Natl Acad Sci USA. 2011; 108: 14416-21.
47. Peterlik H, Roschger P, Klaushofer K, Fratzl P., From brittle to ductile fracture of bone. Nat Mater. 2006; 5 (1): 52-5.
48. Jepsen KJ, Goldstein SA, Kuhn JL, Schaffler MB, Bonadio J., Type-I collagen mutation compromises the post-yield behavior of Mov13 long bone. J Orthop Res. 1996; 14 (3): 493-9.
49. Mehta SS, Antich PP, Landis WJ., Bone material elasticity in a murine model of osteogenesis imperfecta. Connect Tissue Res. 1999; 40 (3): 189-98.
50. Jepsen KJ, Schaffler MB, Kuhn JL, Goulet RW, Bonadio J, Goldstein SA., Type I collagen mutation alters the strength and fatigue behavior of Mov13 cortical tissue. J Biomech. 1997; 30 (11-12): 1141-7.
51. Camacho NP, Landis WJ, Boskey AL., Mineral changes in a mouse model of osteogenesis imperfecta detected by Fourier transform infrared microscopy. Connect Tissue Res. 1996; 35 (1-4): 259-65.
52. Wasserman N, Yerramshetty J, Akkus O., Microcracks colocalize within highly mineralized regions of cortical bone tissue. Eur J Morphol. 2005; 42: 43-51.
53. Li H, Jiang X, Delaney J, et al. Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine. Am J Pathol. 2010; 176: 2405-13.
54. Currey JD., The mechanical consequences of variation in the mineral content of bone. J Biomech. 1969; 2 (1): 1-11.
55. Currey JD., The relationship between the stiffness and the mineral content of bone. J Biomech. 1969; 2 (4): 477-80.
56. Chang SW, Shefelbine SJ, Buehler MJ., Structural and mechanical differences between collagen homo- and heterotrimers: relevance for the molecular origin of brittle bone disease. Biophys J. 2012; 102: 640-8.
57. Cole WG., The Nicholas Andry Award-1996. The molecular pathology of osteogenesis imperfecta. Clin Orthop Relat Res. 1997 (343): 235-48.
58. Cole WG., Advances in osteogenesis imperfecta. Clin Orthop Relat Res. 2002; (401): 6-16.
59. Knott L, Whitehead CC, Fleming RH, Bailey AJ., Biochemical changes in the collagenous matrix of osteoporotic avian bone. Biochem J. 1995; 310: 1045-51.
60. Phillips CL, Pfeiffer BJ, Luger AM, Franklin CL., Novel collagen glomerulopathy in a homotrimeric type I collagen mouse (oim). Kidney Int. 2002; 62: 383-91.
61. Vashishth D., The role of the collagen matrix in skeletal fragility. Curr Osteoporos Rep. 2007; 5 (2): 62-6.
62. Wang X, Shen X, Li X, Agrawal CM., Age-related changes in the collagen network and toughness of bone. Bone. 2002; 31 (1): 1-7.
63. Coleman RM, Aguilera L, Quinones L, Lukashova L, Poirier C, Boskey A., Comparison of bone tissue properties in mouse models with collagenous and non-collagenous genetic mutations using FTIRI. Bone. 2012; 51 (5): 920-8.